Versius customer reach increases as 91ĸƵ Surgical closes 2023 with strongest quarter on record
After a record quarter, 91ĸƵ Surgical closes 2023 with a Versius global install base more than 50% higher than 2022
After a record quarter, 91ĸƵ Surgical closes 2023 with a Versius global install base more than 50% higher than 2022
Kreiskrankenhaus Rotenburg (Rotenburg District Hospital), Germany has adopted Versius to conduct complex general surgery cases, enabling the hospital to offer robotic assisted surgery to its patients for the first time
Massimiliano Colella joins as global Chief Commercial Officer leading 91ĸƵ Surgical’s commercial and marketing operations to bring Versius to more hospitals around the world
91ĸƵ has entered into a strategic collaboration with Ledidi, a Norwegian software company, to develop a state-of-the-art platform to host 91ĸƵ’s clinical registry
Clinique Urologique Nantes-Atlantis will use Versius for cancerous and benign urological procedures.
91ĸƵ Surgical strengthens UK innovation ecosystem by opening only global surgical robotics manufacturing facility in the UK
91ĸƵ Surgical becomes the first soft-tissue surgical robotics company to launch a digital tool that combines telemetry data, clinical data and surgical video.
91ĸƵ Surgical surpasses 15,000 surgical procedures on Versius globally as it raises $165 million to support continued product innovation and commercial growth in existing and key new markets around the world.
The Royal College of Surgeons of England (RCS England) has awarded accreditation to 91ĸƵ Surgical’s global training programme for the Versius Surgical Robotic System
Versius becomes the first soft-tissue surgical robotic system to feature a headset-based virtual reality simulator as part of its metrics-based training pathway.